Cargando…
Preeclampsia and the Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is characterized by venous or arterial thrombosis and/or adverse pregnancy outcome in the presence of persistent laboratory evidence of antiphospholipid antibodies (aPLs). Preeclampsia complicates about 10–17% of pregnancies with APS. However, only early onset preecla...
Autores principales: | Mayer-Pickel, Karoline, Nanda, Manurishi, Gajic, Maja, Cervar-Zivkovic, Mila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452741/ https://www.ncbi.nlm.nih.gov/pubmed/37626793 http://dx.doi.org/10.3390/biomedicines11082298 |
Ejemplares similares
-
Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy
por: Mayer-Pickel, Karoline, et al.
Publicado: (2015) -
The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas
por: Gajić, Maja, et al.
Publicado: (2023) -
Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
por: Mayer-Pickel, Karoline, et al.
Publicado: (2019) -
The impact of resilience on psychological outcomes in women after preeclampsia: an observational cohort study
por: Mautner, Eva, et al.
Publicado: (2013) -
Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report
por: Skoura, Rafailia, et al.
Publicado: (2022)